|
Age (years, mean ± SD & range)
|
43.2 ± 12.9 (21–62)
|
|
Sex (male/female)
|
119/36 (76.8/23.2%)
|
|
BMI (kg/m2, mean ± SD)
|
25.6 ± 2.9
|
|
Average weight (BMI < 25)
|
68 (43.9%)
|
|
Overweight (BMI 25–30)
|
87 (56.1%)
|
|
Obese (BMI > 30)
|
0
|
|
Serum albumin (g/dL, mean ± SD)
|
3.8 ± 0.7
|
|
Serum bilirubin (mg/dL, median & range)
|
1.4 (0.6–5.8)
|
|
ALT (U/L, mean ± SD)
|
41.5 ± 20.3
|
|
AST (U/L, mean ± SD)
|
38.9 ± 18.3
|
|
ALP (U/L, mean ± SD)
|
119.4 ± 48.7
|
|
Platelet count (103/µL, U/L, mean ± SD)
|
201.7 ± 72.2
|
|
HCV RNA (IU/mL, median & range)
|
4.5 × 105 (9 × 103–8 × 106)
|
|
Histopathological data
| |
|
Fibrosis stage (F1/F2/F3/F4)
|
54/62/13/26 (34.8/40/8.4/16.8)
|
|
Hepatitis grades (G1/G2/G3)
|
68/58/29 (43.9/37.4/18.7)
|
|
Steatosis (no/mild/moderate/severe)
|
23/44/44/21 (29.7/28.4/28.4/13.5)
|
|
MDCT data
| |
|
CT ratio (mean ± SD, range)
|
1.1 ± 0.2 (0.3–1.4)
|
|
MRI data
| |
|
T1-fat fraction (median & range)
|
− 13.5 (− 32.5 to 30.4)
|
|
Fat percentage (median & range)
|
4.8 (− 5.2 to 33.4)
|
|
T2 fat suppression (median & range)
|
0.1 (− 22.5 to 22.2)
|
|
Proton density fat fraction% (PDFF) (median & range)
|
6.2 (0.6–35.2)
|
|
ADC for hepatic fibrosis (× 10−3 mm2/s) (median & range)
|
1.2 (0.97–1.4)
|
